Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients

Breast Cancer Research and Treatment

Volumn 134, Issue 3, 2012, Pages 1189-1197

  Kang, Eunyoung ^a   Park, Sue K ^b   Yang, Jae Jeong ^b   Park, Boyoung ^b,c   Lee, Min Hyuk ^d   Lee, Jong Won ^e   Suh, Young Jin ^f   Lee, Jeong Eon ^g   Kim, Hyun Ah ^h   Oh, Se Jeong ^i,j   Kim, Sung Won ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c National Cancer Center   (South Korea)

^d Soonchunhyang University College of Medicine   (South Korea)

^e University of Ulsan   (South Korea)

^f The Catholic University of Korea   (South Korea)

^g Sungkyunkwan University   (South Korea)

^h Korea Cancer Center Hospital   (South Korea)

ⁱ Bupyeong gu   (South Korea)

^j Target Molecule Study Group   (South Korea)

more..

Author keywords

BRCA; BRCAPRO; Mutation; Myriad II; Prediction model

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BILATERAL CANCER; BRCAPRO MODEL; BREAST CANCER; CANCER STAGING; CLINICAL EVALUATION; EARLY CANCER; ETHNIC GROUP; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC MODEL; GENETIC RISK; GENETIC SCREENING; HETEROZYGOTE; HUMAN; INTERMETHOD COMPARISON; KOREA; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; MYRIAD II MODEL; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

ADULT; AGE OF ONSET; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; MUTATION; PROGNOSIS; REPUBLIC OF KOREA; ROC CURVE; YOUNG ADULT;

EID: 84868215262     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2022-8     Document Type: Article

References (25)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117-1130. doi:10.1086/375033
2. Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701-2712
3. Vogel KJ, Atchley DP, Erlichman J, Broglio KR, Ready KJ, Valero V, Amos CI, Hortobagyi GN, Lu KH, Arun B (2007) BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol 25(29):4635-4641. doi:10.1200/JCO.2006.10.4703
4. Huo D, Senie RT, Daly M, Buys SS, Cummings S, Ogutha J, Hope K, Olopade OI (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, Hispanic, and other minority families in the United States. J Clin Oncol 27(8):1184-1190. doi:10.1200/JCO.2008.17.5869
5. Van Harssel JJ, Van Roozendaal CE, Detisch Y, Brandao RD, Paulussen AD, Zeegers M, Blok MJ, Gomez Garcia EB (2010) Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection. Fam Cancer 9(2):193-201. doi:10.1007/s10689-009-9305-1
6. Kurian AW, Gong GD, Chun NM, Mills MA, Staton AD, Kingham KE, Crawford BB, Lee R, Chan S, Donlon SS, Ridge Y, Panabaker K, West DW, Whittemore AS, Ford JM (2008) Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol 26(29):4752-4758. doi:10.1200/JCO.2008.16.8310
7. Ko SS (2008) Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update. J Surg Oncol 98(5):318-323. doi:10.1002/jso.21110
8. Kang E, Ahn SH, Noh WC, Noh DY, Jung Y, Kim LS, Choi DH, Suh YJ, Kim KS, Lee JE, Lee MH, Nam SJ, Moon BI, Son BH, Yang JH, Yom CK, Kim SY, Park SK, Kim SW (2010) The KOHBRA study has changed the practice patterns for managing hereditary breast cancer in Korea. J Breast Cancer 13(4):351-356
9. Kim EK, Kim KS, Park SK, Ahn SH, Lee MH, Kim SW, Korean Breast Cancer Society (2007) The Korean Hereditary Breast Cancer (KOHBRA) Study: protocol rewiew. J Breast Cancer 10(4):241-247
10. Han SA, Park SK, Hyun Ahn S, Hyuk Lee M, Noh DY, Kim LS, Noh WC, Jung Y, Sang Kim K, Kim SW, Korean Breast Cancer Study Group (2011) The Korean Hereditary Breast Cancer (KOHBRA) Study: protocols and interim report. Clin Oncol (R Coll Radiol) 23(7):434-441. doi:10.1016/j.clon. 2010.11.007
11. Choi DH, Lee MH, Bale AE, Carter D, Haffty BG (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22(9):1638-1645. doi:10.1200/JCO. 2004.04.179 JCO.2004.04.179
12. Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S, Douglas F, Eccles D, Morrison PJ, Scott J, Zimmern RL, Easton DF, Pharoah PD (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 45(7):425-431. doi:10.1136/jmg.2007.056556
13. Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62(1):145-158
14. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10, 000 individuals. J Clin Oncol 20(6):1480-1490
15. Parmigiani G, Chen S, Iversen ES, Jr, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM (2007) Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147(7):441-450
16. Kurian AW, Gong GD, John EM, Miron A, Felberg A, Phipps AI, West DW, Whittemore AS (2009) Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 18(4):1084-1091. doi:10.1158/1055-9965. EPI-08-1090
17. Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294(15):1925-1933. doi:10.1001/jama.294.15.1925
18. Rao NY, Hu Z, Li WF, Huang J, Ma ZL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM (2009) Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat 113(3):467-477. doi:10.1007/s10549-008-9965-9
19. Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20(6):413-424. doi:10.1002/humu.10154
20. Jung YS, Na KY, Kim KS, Ahn SH, Lee SJ, Park HK, Cho YU (2011) Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program. J Breast Cancer 14(3):229-236. doi:10.4048/jbc.2011.14.3. 229
21. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (2010) SEER Cancer Statistics Review 1975-2008. National Cancer Institute. http://seer.cancer.gov/csr/1975-2008/xs. Accessed 7 September 2011
22. Kelsey JL, Horn-Ross PL (1993) Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15(1):7-16
23. Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR, Palomares MR, Lowstuter KJ, MacDonald DJ (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297(23):2587-2595. doi:10.1001/jama.297.23.2587
24. American Society of Clinical Oncology (1996) Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol. 14(5):1730-1736; discussion 1737-1740
25. Seong MW, Cho SI, Noh DY, Han W, Kim SW, Park CM, Park HW, Kim SY, Kim JY, Park SS (2009) Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population. Fam Cancer 8(4):505-508. doi:10.1007/s10689-009-9279-z